Treatment of Tremor in Parkinson's Disease
Tremor is a prominent and often disabling motor feature of Parkinson's disease. When tremor persists or predominates — including postural tremor — the treatment approach requires specific consideration beyond the standard management of akinesia and rigidity.
Clinical Scenario
This protocol addresses Parkinson's disease where tremor is the key presenting or ongoing symptom. For patients whose tremor is not adequately controlled on standard dosing, further pharmacological adjustment may be warranted.
Treatment Approach (partial overview)
The structured regimen involves optimisation of dopaminergic therapy — including Levodopa and dopamine agonists, which may be used individually or in combination — along with additional agents that can be considered for specific tremor subtypes. The complete sequencing, selection criteria, and dosing algorithm are in the full protocol…
References
DOI: 10.1186/s42466-024-00325-4
- For PD tremor refractory to standard Levodopa doses, increasing Levodopa daily dosage or high Levodopa single doses can be helpful in individual cases.
- Dopamine agonists should be used for PD disease symptoms in monotherapy and combination therapy, typically addressing symptoms of akinesia and rigidity, which often also improves Parkinson's tremor equivalently.
- Betablockers may be considered for treating postural PD tremor (off-label).
View source ↗